Annual, J.P. Morgan

Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference
Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that Co-Founder and CEO, Jason Kelly, is scheduled to present at the 43rd Annual J.
Perspective Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
43rd Annual J.P. Morgan Healthcare Conference – Company Presentation Date: Wednesday, January 15, 2025 Time: 3:45 p.m. - 4:25 p.m. PT Location: The Westin St. Francis Hotel, San Francisco, CA (Elizabethan B)
Samsung, Celltrion to exhibit at J.P. Morgan Healthcare Conference
Korean biopharmaceutical firms Samsung Biologics, Celltrion, and Lotte Biologics will showcase their advancements at the J.P. Morgan Healthcare Conference.
Celltrion to reveal four-year road map at J.P. Morgan Healthcare Conference
Celltrion will reveal its dual-track strategy to juggle the development of both biosimilars and original drugs at the J.P. Morgan Healthcare Conference.
Immunocore announces strategic priorities at 43rd Annual J.P. Morgan Healthcare Conference
Reaching more mUM patients globally with KIMMTRAK (tebentafusp) in 2025 through additional launches and increased community penetrationEnrolling
Ensem Therapeutics Announces Presentation at 43rd Annual J.P. Morgan Healthcare Conference
Ensem Therapeutics, Inc. (ENSEM), a pioneering drug discovery and development company that leverages its unique Kinetic Ensemble® platform to advance
AKTIS ONCOLOGY TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
Aktis Oncology, an oncology company focused on unlocking the breakthrough potential of targeted radiopharmaceuticals for large patient populations not addressed by existing platform technologies, today announced that Matthew Roden,
Terns Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference
A live webcast of the presentation will be available on the investor relations page of the Terns Pharmaceuticals website at http://ir.ternspharma.com. A replay of the webcasts will be archived on Terns’ website for at least 30 days following the presentatons.
BioUtah to Attend the J.P. Morgan 43rd Annual Healthcare Conference
BioUtah, the trade association, common voice, and flag bearer for Utah's life sciences industry, will participate in the 2025 J.P. Morgan 43rd Annual Healthcare Conference. BioUtah to co-host an RSVP-required reception on Sunday night,
Daré Bioscience to Participate in the Women’s Health Series at the 43rd Annual J.P. Morgan Healthcare Conference
The panel will discuss the value proposition for investing in women’s health.J.P. Morgan is hosting a three-panel women’s health series at this
Modern Healthcare2d
J.P. Morgan increases security for 2025 conference
The J.P. Morgan Healthcare Conference attracts thousands of attendees each year from the provider, insurance, digital health ...
Nvidia In Focus: CES This Week, J.P. Morgan Healthcare Conference Next Week, February Earnings
Then, next week, Nvidia is on the road again at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, which ...
Tenon Medical(R) to Host Meetings During the 2025 J.P. Morgan Healthcare Conference in San Francisco
LOS GATOS, CA / ACCESSWIRE / / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for ...